Heintz AP - Search Results

1

Continuous infusion of 5-fluorouracil in ovarian cancer patients refractory to cisplatin and carboplatin.

de Graeff A, van Hoef ME, Tjia P, Heintz AP, Neijt JP. de Graeff A, et al. Among authors: heintz ap. Ann Oncol. 1991 Oct;2(9):691-2. doi: 10.1093/oxfordjournals.annonc.a058052. Ann Oncol. 1991. PMID: 1742226 Free article. No abstract available.

2

Long-term survival in ovarian cancer. Mature data from The Netherlands Joint Study Group for Ovarian Cancer.

Neijt JP, ten Bokkel Huinink WW, van der Burg ME, van Oosterom AT, Willemse PH, Vermorken JB, van Lindert AC, Heintz AP, Aartsen E, van Lent M, et al. Neijt JP, et al. Among authors: heintz ap. Eur J Cancer. 1991;27(11):1367-72. doi: 10.1016/0277-5379(91)90011-2. Eur J Cancer. 1991. PMID: 1835850 Clinical Trial.

3

The role of cytoreduction in ovarian cancer.

Zanaboni F, Heintz AP, Trimbos JB, van Lindert AC, Aalders JG, Neijt JP. Zanaboni F, et al. Among authors: heintz ap. Eur J Gynaecol Oncol. 1988;9(2):149-52. Eur J Gynaecol Oncol. 1988. PMID: 3133212

4

Quality of life after pelvic exenteration.

Roos EJ, de Graeff A, van Eijkeren MA, Boon TA, Heintz AP. Roos EJ, et al. Among authors: heintz ap. Gynecol Oncol. 2004 Jun;93(3):610-4. doi: 10.1016/j.ygyno.2004.03.008. Gynecol Oncol. 2004. PMID: 15196852

5

Randomized trial comparing two combination chemotherapy regimens (CHAP-5 v CP) in advanced ovarian carcinoma.

Neijt JP, ten Bokkel Huinink WW, van der Burg ME, van Oosterom AT, Willemse PH, Heintz AP, van Lent M, Trimbos JB, Bouma J, Vermorken JB, et al. Neijt JP, et al. Among authors: heintz ap. J Clin Oncol. 1987 Aug;5(8):1157-68. doi: 10.1200/JCO.1987.5.8.1157. J Clin Oncol. 1987. PMID: 3114434 Clinical Trial.

6

Cytoreductive surgery with or without preceding chemotherapy in ovarian cancer.

Neijt JP, Aartsen EJ, Bouma J, Heintz AP, van Lent M, van Lindert AC. Neijt JP, et al. Among authors: heintz ap. Prog Clin Biol Res. 1985;201:217-23. Prog Clin Biol Res. 1985. PMID: 4095113 No abstract available.

7

Sequential cisplatin--doxorubicin, early debulking in advanced ovarian cancer.

Heintz AP. Heintz AP. Eur J Cancer. 1992;28A(6-7):1009-10. doi: 10.1016/0959-8049(92)90441-4. Eur J Cancer. 1992. PMID: 1627364 Review. No abstract available.

8

The treatment of advanced ovarian carcinoma (I): clinical variables associated with prognosis.

Heintz AP, Van Oosterom AT, Trimbos JB, Schaberg A, Van der Velde EA, Nooy M. Heintz AP, et al. Gynecol Oncol. 1988 Jul;30(3):347-58. doi: 10.1016/0090-8258(88)90249-1. Gynecol Oncol. 1988. PMID: 3134277

9

Is platinum-based chemotherapy with paclitaxel effective in optimally debulked patients with advanced ovarian cancer?

Roovers JP, Sijmons EA, van Leeuwen JH, Mol BW, Witteveen PO, Slee PH, Heintz AP. Roovers JP, et al. Among authors: heintz ap. Eur J Obstet Gynecol Reprod Biol. 2001 Jul;97(1):80-4. doi: 10.1016/s0301-2115(00)00502-9. Eur J Obstet Gynecol Reprod Biol. 2001. PMID: 11435015

10

Surgery in advanced ovarian carcinoma: is there proof to show the benefit?

Heintz AP. Heintz AP. Eur J Surg Oncol. 1988 Apr;14(2):91-9. Eur J Surg Oncol. 1988. PMID: 3360164

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

180 results

Search Page

Filters